why choose us

First received: January 1, 2023

Clinical Trial: Pirfenidone in Adult Hospitalized Patients With COVID-19

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: COVID-19 Pneumonia

Study Type: Interventional


Official Title: A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pirfenidone in Adult Hospitalized Patients With COVID-19.

Brief Summary: This center intends to conduct a multicenter, randomized, placebo-controlled study to evaluate the effectiveness and safety of Nintedanib ethanesulfonate soft capsule in the treatment of pulmonary fibrosis in patients with moderate to severe COVID-19.

Read more